gamma-aminobutyric acid has been researched along with Cerebral Palsy in 16 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Cerebral Palsy: A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cerebral palsy is among the most frequent disorders of the growing locomotor apparatus during childhood." | 2.41 | [Botulinum toxin type A in the treatment plan for cerebral palsy]. ( Strobl, W, 2001) |
| "Weakness as well as spasticity due to lack of selective neuronal control causes functional impairment and additional mechanisms of compensation, retardation of motor development, secondary deformities of muscles and soft tissues due to a failure of muscle growth, subluxation/dislocation of joints, early osteoarthritis, and pain." | 2.41 | [Botulinum toxin type A in the treatment plan for cerebral palsy]. ( Strobl, W, 2001) |
| "Epilepsy is common in individuals who are mentally retarded and/or otherwise multiply handicapped." | 2.39 | The role of the old and the new antiepileptic drugs in special populations: mental and multiple handicaps. ( Mattson, RH, 1996) |
| "An animal model of chronic spasticity would be valuable." | 2.38 | The spastic mouse. And the search for an animal model of spasticity in human beings. ( Rang, M; Wright, J, 1990) |
| "Mean pre-withdrawal pregabalin dosage was 386 mg/day, decreasing to 70 mg/day at mean lowest dosage." | 1.39 | Spasticity increases during pregabalin withdrawal. ( Baguley, IJ; Braid, JJ; Kirker, SG, 2013) |
| "Median subjective spasticity scores increased from 4 at baseline to 6 at lowest dose (p < 0." | 1.39 | Spasticity increases during pregabalin withdrawal. ( Baguley, IJ; Braid, JJ; Kirker, SG, 2013) |
| "Six children with cerebral palsy are presented who developed neuropathic pain following multilevel orthopedic surgery." | 1.33 | Neuropathic pain following multilevel surgery in children with cerebral palsy: a case series and review. ( Lauder, GR; White, MC, 2005) |
| "Twenty children had spastic diplegia and three had quadriplegia." | 1.33 | Metabolite profile in the basal ganglia of children with cerebral palsy: a proton magnetic resonance spectroscopy study. ( Kubas, B; Kulak, W; Smigielska-Kuzia, J; Sobaniec, W; Walecki, J, 2006) |
| "EEG showed typical hypsarrhythmia in 8 cases, asymmetrical hypsarrhythmia in 1 case and modified hypsarrhythmia in another case." | 1.30 | [West's syndrome in patients with cerebral paralysis and periventricular leukomalacia: a good response to treatment]. ( Caraballo, R; Cersósimo, R; Fejerman, N; Intruvini, S; Pociecha, J, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (31.25) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batysheva, TT | 1 |
| Platonova, AN | 1 |
| Chebanenko, NV | 1 |
| Bykova, OV | 1 |
| Braid, JJ | 1 |
| Kirker, SG | 1 |
| Baguley, IJ | 1 |
| Arvio, M | 1 |
| Merikanto, J | 1 |
| SHIMIZU, S | 1 |
| BERTAMINO, F | 1 |
| VENTO, R | 1 |
| Strobl, W | 1 |
| Lauder, GR | 2 |
| White, MC | 1 |
| Nordmann, GR | 1 |
| Grier, DJ | 1 |
| Kulak, W | 1 |
| Sobaniec, W | 1 |
| Smigielska-Kuzia, J | 1 |
| Kubas, B | 1 |
| Walecki, J | 1 |
| Mattson, RH | 1 |
| Caraballo, R | 1 |
| Cersósimo, R | 1 |
| Intruvini, S | 1 |
| Pociecha, J | 1 |
| Fejerman, N | 1 |
| Krach, LE | 1 |
| Gershman, RN | 1 |
| Vasilenko, MA | 1 |
| Iliushina, GG | 1 |
| Iakimenko, GD | 1 |
| Iakovleva, SM | 1 |
| Wright, J | 1 |
| Rang, M | 1 |
| Lipkin, PH | 1 |
| Roe, CR | 1 |
| Goodman, SI | 1 |
| Batshaw, ML | 1 |
| Sazonova, NS | 1 |
| Balashova, EG | 1 |
4 reviews available for gamma-aminobutyric acid and Cerebral Palsy
| Article | Year |
|---|---|
[Botulinum toxin type A in the treatment plan for cerebral palsy].
Topics: Activities of Daily Living; Adolescent; Adult; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; C | 2001 |
The role of the old and the new antiepileptic drugs in special populations: mental and multiple handicaps.
Topics: Acetates; Amines; Anticonvulsants; Cerebral Palsy; Cyclohexanecarboxylic Acids; Disabled Persons; Dr | 1996 |
Pharmacotherapy of spasticity: oral medications and intrathecal baclofen.
Topics: Acetates; Administration, Oral; Amines; Anti-Anxiety Agents; Baclofen; Benzodiazepines; Cerebral Pal | 2001 |
The spastic mouse. And the search for an animal model of spasticity in human beings.
Topics: Animals; Cerebral Palsy; Disease Models, Animal; Electric Stimulation; gamma-Aminobutyric Acid; Huma | 1990 |
2 trials available for gamma-aminobutyric acid and Cerebral Palsy
| Article | Year |
|---|---|
[Management of cognitive impairment in children and adolescents with cerebral palsy treated with pantocalcin].
Topics: Adolescent; Anxiety; Attention; Cerebral Palsy; Child; Cognition; Female; gamma-Aminobutyric Acid; H | 2013 |
[Gammalon in the rehabilitation in infantile cerebral palsy].
Topics: Aminobutyrates; Cerebral Palsy; Child; Clinical Trials as Topic; Drug Evaluation; Electroencephalogr | 1977 |
10 other studies available for gamma-aminobutyric acid and Cerebral Palsy
| Article | Year |
|---|---|
Spasticity increases during pregabalin withdrawal.
Topics: Analgesics; Anticonvulsants; Brain Injuries; Cerebral Palsy; Drug Administration Schedule; Female; g | 2013 |
[A relief from neural pain--gabapentin helped against hip ache in a girl with cerebral palsy].
Topics: Acetates; Adolescent; Amines; Analgesics; Arthralgia; Cerebral Palsy; Cyclohexanecarboxylic Acids; F | 2001 |
[Use of aminobutyric acid (GABA) in congenital oligophrenia and in infantile cerebral paralysis].
Topics: Amino Acids; Aminobutyrates; Antifibrinolytic Agents; Cerebral Palsy; Diet, Reducing; gamma-Aminobut | 1961 |
[GABOB IN PEDIATRICS. CLINICAL AND ELECTROENCEPHALOGRAPHIC STUDY OF 28 CASES].
Topics: Adolescent; Aminobutyrates; Barbiturates; Brain Injuries; Cerebral Palsy; Child; Electroencephalogra | 1964 |
Neuropathic pain following multilevel surgery in children with cerebral palsy: a case series and review.
Topics: Adolescent; Amines; Amitriptyline; Analgesics; Antidepressive Agents, Tricyclic; Cerebral Palsy; Chi | 2005 |
Computed tomography guided lumbar sympathetic block for complex regional pain syndrome in a child: a case report and review.
Topics: Amines; Amitriptyline; Analgesics; Anesthetics, Local; Antidepressive Agents, Tricyclic; Autonomic N | 2006 |
Metabolite profile in the basal ganglia of children with cerebral palsy: a proton magnetic resonance spectroscopy study.
Topics: Adolescent; Apgar Score; Aspartic Acid; Basal Ganglia; Cerebral Palsy; Child; Child, Preschool; Chol | 2006 |
[West's syndrome in patients with cerebral paralysis and periventricular leukomalacia: a good response to treatment].
Topics: Anticonvulsants; Atrophy; Cerebral Palsy; Cerebral Ventricles; Child; Child, Preschool; Female; gamm | 1997 |
A case of glutaric acidemia type I: effect of riboflavin and carnitine.
Topics: Amino Acid Metabolism, Inborn Errors; Basal Ganglia Diseases; Carnitine; Cerebral Palsy; Child, Pres | 1988 |
[Experience with clinical use of the drug gammalon in children with cerebral palsy].
Topics: Adolescent; Aminobutyrates; Cerebral Palsy; Child; Child, Preschool; Electromyography; Feeding and E | 1974 |